Astec Lifesciences Debt & Borrowing: ₹25 Cr
Astec LifeSciences Limited has redeemed Commercial Papers amounting to ₹25 Crore. The payment was made on the maturity date, 13th October, 2026.
- Value
- ₹25.00 Cr
ALFA Filings
Every announcement, straight from the exchange
Every Astec Lifesciences debt & borrowing announcement on NSE and BSE, newest first, each with its own page.
Time
9 announcements with these filters
Astec LifeSciences Limited has redeemed Commercial Papers amounting to ₹25 Crore. The payment was made on the maturity date, 13th October, 2026.
Astec LifeSciences fixed record dates for redemption of three CP series totaling Rs.75 Crore maturing Nov–Dec 2026. All three CPs are listed on the NSE debt segment.
Astec LifeSciences Limited has confirmed the timely payment of the maturity amount for its commercial paper. The redemption amount totals ₹25 Crore.
Astec LifeSciences has set record dates for the redemption of three Commercial Paper series, with each series maturing at a value of ₹25 Crore.
Astec LifeSciences Limited successfully redeemed its listed Commercial Paper worth ₹25 Crore on maturity. The timely payment reinforces the company's financial discipline and debt servicing reliability.
Astec LifeSciences Limited confirmed the timely redemption of ₹25 Crore worth of Commercial Papers. The payment was made upon maturity on May 22, 2026.
Astec LifeSciences fixed June 2026 record dates for redeeming four Commercial Paper series. Investors should track these dates to ensure timely receipt of maturity payments.
Astec LifeSciences Limited confirmed the timely redemption and payment of ₹25 Crore for its Commercial Papers (Series ASTEC-CP-186). The papers matured on April 29, 2026. This announcement demonstrates the company's adherence to its debt obligations and financial stability.
Astec LifeSciences Limited has fixed the record dates for the redemption of two Commercial Paper series maturing in May 2026. The total redemption amount is ₹50 Crore, split across two ₹25 Crore tranches listed on the NSE.